TOSCANO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 466
EU - Europa 253
AS - Asia 158
AF - Africa 92
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 995
Nazione #
US - Stati Uniti d'America 460
IT - Italia 135
SG - Singapore 89
CI - Costa d'Avorio 65
IE - Irlanda 63
CN - Cina 49
SN - Senegal 26
BR - Brasile 22
FI - Finlandia 9
IN - India 9
NL - Olanda 9
DE - Germania 7
GB - Regno Unito 7
RU - Federazione Russa 6
CA - Canada 5
FR - Francia 5
HK - Hong Kong 4
UA - Ucraina 4
CZ - Repubblica Ceca 3
UZ - Uzbekistan 3
AT - Austria 2
VE - Venezuela 2
VN - Vietnam 2
BD - Bangladesh 1
CH - Svizzera 1
EC - Ecuador 1
EU - Europa 1
MA - Marocco 1
MX - Messico 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
Totale 995
Città #
Santa Clara 138
Chandler 73
Abidjan 65
Dublin 55
Singapore 55
Chicago 36
Civitanova Marche 34
Dakar 26
Ashburn 25
Boardman 25
Catania 15
Milan 12
Andover 11
Cambridge 11
Lawrence 11
Wilmington 8
Lappeenranta 5
Los Angeles 5
Rome 5
Toronto 5
Bari 4
Helsinki 4
São Paulo 4
Vicenza 4
Beijing 3
Bengaluru 3
Bernareggio 3
Bremen 3
Brno 3
Capannori 3
Des Moines 3
Mascalucia 3
Mola di Bari 3
Padova 3
Pune 3
Scheggia e Pascelupo 3
Seattle 3
Agrigento 2
Dong Ket 2
Fairfield 2
Giarre 2
Hong Kong 2
London 2
Menlo Park 2
Nanjing 2
Pescara 2
Pioltello 2
Pontedera 2
Saint Petersburg 2
San Giovanni la Punta 2
Araraquara 1
Artur Nogueira 1
Bangalore 1
Barbacena 1
Belford Roxo 1
Belo Horizonte 1
Bologna 1
Botucatu 1
Bucharest 1
Campos dos Goytacazes 1
Carmópolis 1
Casablanca 1
Central 1
Cunha 1
Edinburgh 1
Florence 1
Fortaleza 1
Guarenas 1
Guayaquil 1
Guiyang 1
Hyderabad 1
Itanhaém 1
Jacksonville 1
Jiaxing 1
Kalyān 1
Lausanne 1
Mexico City 1
Munich 1
Paola 1
Porto Alegre 1
Pozzo Di Gotto 1
Sala Baganza 1
Salvador 1
San Francisco 1
San Mateo 1
Santana do Araguaia 1
Shanwei 1
Shenyang 1
Sorocaba 1
São Sebastião 1
Taizhou 1
Tashkent 1
Tianjin 1
Umbaúba 1
Uruçuca 1
Valencia 1
Vespolate 1
Vienna 1
Washington 1
Zhengzhou 1
Totale 751
Nome #
Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson's disease 74
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 71
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 71
An update on the safety of treating relapsing-remitting multiple sclerosis 69
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 65
Biomarcatori diagnostici e prognostici nella Sclerosi Multipla: un approccio multidimensionale 58
An update on the pharmacological management of pain in patients with multiple sclerosis 52
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 50
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 45
Letter to the editors: comment on “Emerging themes in idiopathic intracranial hypertension” 43
REal-World effectIveNess of claDribine for patients with multiple sclerosis: a Sicilian multicentric experience (REWIND study) 42
Rituximab for the treatment of multiple sclerosis: a review 41
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 39
CSF biomarkers in multiple sclerosis: beyond neuroinflammation 39
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 37
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 36
Palliative care in multiple sclerosis 35
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 34
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 27
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis 25
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study 21
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 21
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 19
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 17
Reliability of televisits for patients withmild relapsing-remitting multiple sclerosis in the COVID-19 era, Neurological Science 7
Totale 1.038
Categoria #
all - tutte 4.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 1 0 1 1
2020/202132 5 0 4 2 11 0 0 0 3 0 3 4
2021/202292 2 9 6 13 13 1 14 6 2 0 0 26
2022/2023239 12 13 6 15 23 29 2 70 57 1 11 0
2023/2024228 10 45 10 9 11 55 4 13 8 3 44 16
2024/2025429 14 75 26 47 97 88 31 14 37 0 0 0
Totale 1.038